Epidemiology of candidemia in ICU;Epidemiología de la candidemia en UCI

Revista Iberoamericana de Micologia

Volumn 23, Issue 1, 2006, Pages 12-15

  Galván, Beatriz ^a   Mariscal, Francisco ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Candidemia; Critical non neutropenic patient; Epidemiology

Indexed keywords

CANDIDA; CANDIDIASIS; ECONOMIC ASPECT; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MORTALITY; MYCOSIS; PREVALENCE; REVIEW;

CANDIDA; CANDIDA ALBICANS;

EID: 32644440002     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(06)70005-5     Document Type: Review

References (26)

1. Almirante B, Rodríguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sánchez F, Ayats J, Gimenez M, Saballs P, Fridkin SK, Morgan J, Rodriguez-Tudela JL, Warnock DW, Pahissa A, and the Barcelona Candidemia Project Study Group. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005; 43: 1829-1835.
2. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Tolson J, Henderson T, Martone WJ, and National nosocomial infections surveillance system. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991; 91 (Suppl 2): S86-S89.
3. Beck-Sagué CM, Jarvis WR, and the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993; 167: 1247-1251.
4. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002; 113: 480-485.
5. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP; National Epidemiology of Mycoses Survey (NEMIS) Study Group. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: NEMIS prospective multicentre study. Clin Infect Dis 2001; 33: 177-186.
6. Flanagan PG, Barnes RA. Fungal infection in the intensive care unit. J Hosp Infect, 1998; 38: 163-177.
7. Garbino J, Lew DP, Romand JA, Hogonnet S, Auckenthaler R, Pittet D. Prevention of severe Candida infections in noneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002; 28: 1708-1717.
8. Garbino J, Kolarova I, Rohner P, Lew D, Pincha P, Pittet D. Secular trends of candidemia over 12 year in adult patients at a terciary care hospital. Medicine 2000; 81: 425-435.
9. Jordá R and EPCAN Group Project. Intensive Care Med 1999; 25 (Suppl 1): 171 (Abstract 666).
10. López Dupla M, García-Tobaruela A, Lavilla Uriel P, Gil Aguado A. Candidiasis diseminada. En: Gil Aguado A, Lavilla Uriel P, Pintado García V (Eds.) Micosis sistémicas. Actualización. Madrid, Grupo Aula Médica, 1997: 1-23.
11. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Täuber MG, Pittet D, for the Fungal Infection Network of Switzerland. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004; 38: 311-320.
12. Nolla-Salas J, Sitges-Serra A, León-Gil C, Martínez- Gonzalez J, León-Regidor MA, Ibáñez-Lucia P, Torres-Rodríguez JM. Candidemia in non-neutropenic critically ill patients: análisis of prognosis factors and assesment of systemic antifungal therapy. Intensive Care Med 1997;23:23-30.
13. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut. Clin Infect Dis 2001; 33: 1959-1967.
14. Olaechea PM, Palomar M, Leon-Gil C, Alvarez-Lerma F, Jorda R, Nolla-Salas J, Leon-Regidor MA; EPCAN Study Group. Economic impact of Candida colonization and Candida infection in the critically ill patients. Eur J Clin Microbiol Infect Dis 2004; 23: 323-330.
15. Pemán J, Cantón E, Gobernado M, and the Spanish ECMM Working Group on Candidaemia. Epidemiology and antifungal susceptibility of Candida species isolated from blood:result of a 2-year multicentre atudy in Spain. Eur J Clin Microbiol Infect Dis, 2005; 24: 23-30.
16. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, Messer SA, and The SENTRY Participant Group. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254-3259.
17. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National epidemiology of mycoses survey: a multicenter study of strain variaton and antifungal susceptibility among isolates on Candida species. Diagn Microbiol Infect Dis 1998; 31: 327-332.
18. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated population based model. Clin Infect Dis 1997; 24: 1068-1078.
19. Richards MJ, Edwards MS, Culver DH, Gaynes RP, the National Nosocomial Infections Surveillance System. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21: 510-515.
20. Rocco TR, Reinert E, Simms H. Effects of fluconazole administration in critically ill patients. Arch Surg 2000; 135: 160-165.
21. Solomkin JS, Flohr AM, Simmons RL. Indications for therapy for fungemia in postoperative patients. Arch Surg 1982; 117: 1272-1275.
22. Tortorano AM, Biraghi E, Astolfi A, Ossi C, Tejada M, Farina C, Perin S, Bonaccorso C, Cavanna C, Ravallo A, Grossi A, and FIMUA Candidemia Study Group. European Confederation of Medical Mycology (ECMM) prospective survey of candidemia: report from one Italian region. J Hosp Infect; 51: 297-304.
23. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Canton E, Zimmermann K, Seaton S, Grillot R, and the ECMM Working Group on Candidaemia. Epidemiology of Candidaemia in Europe. Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317-322.
24. Trick WE, Fridkin K, Edwards JR, Hajjeh RA, Gaynes RP, and the National Nosocomial Infections Surveillance System Hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35: 627-630.
25. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infections in intensive care units in Europe. Results of the european prevalence on infections in intensive care (EPIC) study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644.
26. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors of hospital-acquired candidemia: a matched case-control study. Arch Intern Med 1989; 149: 2349-2353.